Articles

Articles | Guidelines 

January 2015

  1. Editorial

Is hepatitis C subtyping still relevant in the era of direct-acting antiviral therapy?

Mohammed EslamJacob George Pages 5-8

  1. Review Article

How to achieve immune control in chronic hepatitis B?

Margo J. H. van CampenhoutHarry L. A. Janssen Pages 9-16

  1. Original Article 

Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection

Huei-Ru ChengJia-Horng KaoHui-Lin WuTai-Chung Tseng… Pages 35-42

  1. Original Article 

Reimbursement policies in the Asia-Pacific for chronic hepatitis B

Seng Gee LimDeepak N. AmarapurkarHenry Lik-Yuen Chan… Pages 43-51

  1. Original Article

HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

  1. Original Article 

A comparative study of patients’ knowledge about hepatitis C in the United States and in urban and rural China

Elizabeth WuXisui ChenZhe GuanClaudia CaoHuiying Rao… Pages 58-66

  1. Original Article 

Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis

Hideyuki TamaiYoshiyuki MoriNaoki ShingakiRyo Shimizu… Pages 67-75

  1. Original Article

High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation

Nabiha FaisalKhalid MumtazMax MarquezEberhard L. Renner… Pages 76-83

April 2015

  1. Review Article

Sofosbuvir for treatment of chronic hepatitis C

Sarah KattakuzhyRachel LevyShyam Kottilil Pages 161-173

  1. Review Article

Management of post transplant hepatitis C in the direct antiviral agents era

Audrey CoillyBruno RocheJean-Charles Duclos-Vallée… Pages 192-201

  1. Original Article 

Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients

Charlie LaohapandEmvalee ArromdeeTawesak Tanwandee  Pages 202-208

  1. Original Article

High rate of core promoter and precore mutations in patients with chronic hepatitis B

Sumbella F. BaqaiJames ProudfootDebbie H. Yi… Pages 209-217

  1. Original Article

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy

Edith Y. HoThomas YauFranck RousseauE. Jenny Heathcote… Pages 224-230

  1. Original Article 

Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection

Ching-Sheng HsuWei-Liang LiuYou-Chen Chao… Pages 231-242

  1. Original Article

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

Maria ButiScott FungEdward GaneNezam H. Afdhal… Pages 243-250

  1. Original Article 

Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians

Susanne KnappZainab ZakariaMohamed HashemHassan Zaghla

July 2015

  1. Review Article 

Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure

Man-Fung Yuen Pages 373-377

  1. Review Article 

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

Heather BennettNathalie WaserKarissa Johnston… Pages 378-390

  1. Original Article

Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis

Zuxiong HuangChun LinJiankai FangNing WangRui Zhou… Pages 416-423

  1. Original Article

HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b

Yosuke HirotsuTatsuo KandaHiroshi Matsumura… Pages 424-430

  1. Original Article

Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients

Pardha DevakiDavid JencksBrittany E. YeeMindie H. Nguyen  Pages 431-437

October 2015

  1. Review Article 

Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries

Masao OmataTatsuo KandaOsamu YokosukaDarrell Crawford… Pages 486-507

  1. Original Article 

Response-guided therapy of regimens based on PEG-interferon for chronic hepatitis B using on-treatment hepatitis B surface antigen quantification: a meta-analysis

Hong PengFang WeiJun-Ying LiuHuai-Dong HuHong Ren… Pages 543-557

  1. Original Article 

Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test

Xueying XuYang SuRuixiang SongYang ShengWensi Ai… Pages 558-566

  1. Original Article

Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis

Myron John TongThatcher Thi HuynhSurachate Siripongsakun… Pages 567-577

  1. Original Article

Interferon-α plus ribavirin yields 98 % sustained virologic response in children aged 1–5 years with iatrogenic chronic hepatitis C

Shi-Shu ZhuQing-Lei ZengYi DongZhi-Qiang XuLi-Min Wang… Pages 578-585

  1. Original Article 

Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies

Alessia PilusoLaura GragnaniElisa FognaniElena Grandini… Pages 586-593

January 2016

  1. Guidelines

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

K. SarinM. KumarG. K. LauZ. AbbasH. L. Y. Chan… Pages 1-98

  1. Editorial

Looking into the crystal ball: biomarkers for outcomes of HBV infection

Hung-Chih YangJia-Horng Kao  Pages 99-101

  1. Editorial

Need to improve awareness and management of hepatitis B reactivation in patients receiving immunosuppressive therapy

Man-Fung Yuen  Pages 102-105

  1. Review Article

Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management

Oscar MitchellArif M. CosarMohammad U. MalikAhmet Gurakar  Pages 106-114

  1. Original Article

Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection

Li WangZhi-Qiang ZouKai WangJi-Guang YuXiang-Zhong Liu  Pages 133-138

  1. Original Article

Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014

Arpan PatelSuna YapaliAnna S. F. Lok Pages 139-146 

  1. Original Article

Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus

Wen-Chun LiuChih-Peng LinChun-Pei ChengCheng-Hsun Ho… Pages 147-157

March 2016

  1. Editorial

Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense

Yuanyuan KongHong YouJidong Jia Pages 239-241

  1. Review Article

Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection

Sheng-Shun YangJia-Horng KaoPages 258-266

  1. Review Article

Advances in therapeutics for chronic hepatitis B

Ninghan YangAntonio BertolettiPages 277-285

  1. Original Article

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan

Chia-Chi WangChih-Lin LinTsai-Yuan HsiehKuo-Chih Tseng… Pages 294-301

  1. Original Article

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment

Dorota KozielewiczWaldemar HalotaMagdalena Wietlicka-Piszcz Pages 302-309

  1. Original Article

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study

Tess PetersenKerry TownsendLori A. Gordon…Pages 310-319

  1. Original Article

Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients

Takao WatanabeYoshio TokumotoKouji JokoKojiro Michitaka…Pages 320-327

May 2016

https://link.springer.com/journal/12072/10/3

  1. Review Article

Prevention and management of hepatitis B virus reactivation in cancer patients

Ka-Shing CheungWai-Kay SetoChing-Lung LaiMan-Fung YuenPages 407-414

  1. Review Article

Hepatitis C virus as a systemic disease: reaching beyond the liver

Kirat GillHasmik GhazinianRichard ManchRobert GishPages 415-423

  1. Review Article

Advances in the management of HIV/HCV coinfection

Mattias MandorferPhilipp SchwablSebastian Steiner…Pages 424-435

  1. Original Article

The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure

Wan Yue-MengLi-Hong YangJin-Hui YangYing XuJing Yang…Pages 462-469

  1. Original Article

Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys

Myong Ki BaegSeung Kew YoonSun-Hye KoKyung-Do Han…Pages 470-477

  1. Original Article

Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis

Edward J. GaneRégine RouzierTarek Hassanein…Pages 478-487

July 2016

  1. Editorial

iNKT cells in chronic HBV: a balancing act

Maike HofmannRobert ThimmePages 535-537

  1. Review Article

HBV culture and infectious systems

Nelson HayesKazuaki ChayamaPages 559-566

  1. Review Article

Hepatitis B virus receptors and molecular drug targets

Eloi R. VerrierChe C. ColpittsCamille Sureau…Pages 567-573

  1. Review Article

Prevention of hepatitis B virus-associated liver diseases by antiviral therapy

Akinobu TawadaTatsuo KandaFumio ImazekiOsamu YokosukaPages 574-593

  1. Original Article

The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection

Man LiZhen-Hua ZhouXue-Hua SunXin ZhangXiao-Jun Zhu…Pages 594-601

  1. Original Article

Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B?

Fuat Ekizİlhami YukselAta Turker ArikökBaris Yilmaz…Pages 602-605

  1. Original Article

Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis

Xueyuan NianZhihui XuYan LiuJianhong ChenXiaodong Li…Pages 606-615

  1. Original Article

Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry

Marina RoytmanResham RamkissoonChristina WuLeena Hong…Pages 616-623

  1. Original Article

Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment

Karla ThorntonPaulina DemingRichard A. ManchAnn Moore…Pages 624-631

September 2016

  1. Guidelines

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

Masao OmataTatsuo KandaLai WeiMing-Lung Yu…Pages 681-701

  1. Guidelines

APASL consensus statements and recommendation on treatment of hepatitis C

Masao OmataTatsuo KandaLai WeiMing-Lung Yu…Pages 702-726

  1. Editorial

HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy

Geoffrey DusheikoBo WangIvana CareyPages 727-729

  1. Review Article

Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals

Che C. ColpittsThomas F. BaumertPages 741-748

  1. Review Article

Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review

Dinesh JothimaniSanjay GovilMohamed RelaPages 749-761

  1. Original Article

Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure

Fabien ZoulimJolanta Białkowska-Warzecha…Pages 779-788

  1. Original Article

Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients

Dong JiGuo-Feng ChenCheng WangYu-Dong WangQing Shao…Pages 789-798

  1. Original Article

HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes

Tien Huey LimEdward GaneChris MoyesBarry Borman…Pages 829-837

November 2016

  1. Review Article

Hepatitis B virus genotypes: epidemiological and clinical relevance in Asia

Qiuju TianJidong JiaPages 854-860

  1. Review Article

Hepatitis C genotype 3 disease

Sarah KattakuzhyRachel LevyElana RosenthalLydia Tang… Pages 861-870

  1. Original Article

Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection

Sukriti SukritiNirupma TrehanpatiManoj Kumar… Pages 916-923

  1. Original Article

Cost-effectiveness analysis of tenofovir disoproxil fumarate for treatment of chronic hepatitis B in China

Weixia KeChi ZhangLi LiuYanhui GaoZhenjiang Yao… Pages 924-936

  1. Original Article

Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis

Shikha ShrivastavaEric G. MeissnerEmily FunkSeerat Poonia… Pages 937-946

  1. Original Article

A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus

Young-Suk LimSang Hoon AhnKwan Sik LeeSeung Woon Paik…Pages 947-955

  1. Original Article

Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy

Hiroko NagataMina NakagawaYuki Nishimura-SakuraiYu Asano…Pages 956-964

  1. Original Article

Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India

Aracely TamayoSamir R. ShahShobna BhatiaAbhijit Chowdhury

Jan 2017

  1. Editorial

Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace

Chih-Lin LinJia-Horng Kao

  1. Review Article

Interferon-free treatment for HCV-infected patients with decompensated cirrhosis

Tatsuo Kanda

  1. Original Article

Molecular mechanisms of HBeAg in persistent HBV infection

Li-Min ChenXue-Gong FanJing MaBo HeYong-Fang Jiang

  1. Original Article

HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea

Chung Hwan JunBan Suk KimChan Young OakDu Hyeon Lee

  1. Original Article 

Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission

Hartono GunardiMelanie Y. IskandarTuryadiSusan I. Ie

March 2017

  1. Review Article

Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection

Chandana PapudesuShyamasundaran KottililShashwatee Ba

  1. Review Article 

Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy

Rebecca LeeShyam KottililEleanor Wilson

  1. Review Article

Virus-induced hepatocellular carcinoma with special emphasis on HBV

Ming WangDong XiQin Ning

  1. Original Article

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

Mark S. SulkowskiWalford J. FesselAdriano Lazzarin

  1. Original Article 

May 2017

  1. Review Article

HCV management in resource-constrained countries

Seng Gee Lim

  1. Original Article

Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis

Mi Young JeonHye Won LeeSeung Up KimJa Yoon Heo

  1. Original Article 

Treatment of chronic hepatitis C genotype 3 with Sofosbuvir-based therpy: a real-life study

Sandeep Singh SidhuNirmaljeet Singh MalhiOmesh Goya

  1. Original Article 

A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C

  1. ShihaS. SeifA. EldesokyM. ElbasionyR. Soliman

July 2017

  1. Review Article 

Current progress in host innate and adaptive immunity against hepatitis C virus infection

Jijing ShiYuanyuan LiWenxian ChangXuexiu Zhang

  1. Original Article 

Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects

Yanhua DingHong ZhangXiaojiao LiCuiyun LiGuiling Chen

  1. Original Article 

Noninvasive serum models to predict significant liver related events in chronic hepatitis C

Ragesh Babu ThandasserySaad Al KaabiMadiha E. Soofi

September 2017

  1. Original Article 

Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B

Tao ChenLin ZhuAichao ShiLin DingXiaoping Zhang

  1. Original Article 

Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis

Zilin TangXiaodong LiShunquan WuYan LiuYan Qiao

  1. Original Article 

Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant

Mohamed ShoreibahJordan OrrDeAnn JonesJie Zhang

  1. Original Article 

A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry

Catherine FauvelleMelanie LambotinLaura Heydmann

November 2017

  1. Point of View 

Viral factors for HBV mother-to-child transmission

James S. ParkCalvin Q. Pan

  1. Point of View 

Mother-to-infant transmission of hepatitis B virus: challenges and perspectives

Yi-Fen ShihChun-Jen Liu

  1. Review Article 

Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread

  1. Karayiannis

Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey

Necati ÖrmeciSimten Malhanİsmail BalıkGül Ergör

January 2018

  1. Original Article

Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?

Simon H. BridgeSabrina PaganoMeleri JonesGraham R. Foster

March 2018

  1. Editorial

Prevention of mother-to-child transmission: the key of hepatitis B virus elimination

Chih-Lin LinJia-Horng Kao

  1. Original Article

The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection

Fan LiXiaodong LiTao YanYan LiuYongqian Cheng

  1. Original Article

Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

Tianyu HeYuqing BaiHaodong CaiXiaojuan OuMin Liu

  1. Original Article

Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study

Lai WeiQing XieJin Lin HouHong TangQin NingJun Cheng

  1. Original Article

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment

Tomomi OkuboMasanori AtsukawaAkihito Tsubota

  1. Original Article

High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy

Rasha EletrebyMohamed SaidZeinab AbdellatifYasmin Saad

  1. Original Article

Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation

Tomoki RyuYuko TakamiYoshiyuki WadaMasaki Tateishi

May 2018

  1. Review Article

Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy

Ameer AbutalebShyam KottililEleanor Wilson

  1. Original Article

Platelets’ increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis

Lin WangBingqiong WangHong YouXiaoning WuJialing Zhou

  1. Original Article

Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan

Fumitaka SuzukiNaoya HatanakaEtsuya BandoKoji Nakamura

July 2018

  1. Editorial

Hepatitis C virus genotype 4-infection and interferon-free treatment in Egypt

Tatsuo KandaShunichi MatsuokaMitsuhiko Moriyama

  1. Review Article

Depression, fatigue and neurocognitive deficits in chronic hepatitis C

Sern Wei YeohAlex C. N. HolmesMichael M. Saling

  1. Review Article

Global HBV burden: guesstimates and facts

Dina GinzbergRobert J. WongRobert GishPages 315-329 

  1. Original Article

Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis

Seogsong JeongGuijuan LuoZhi-Heng WangMeng ShaLei Chen…Pages 330-338 

  1. Original Article

Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience

ShihaR. SolimanM. ElBasionyA. A. Hassan… Pages 339-347 

  1. Original Article

Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4

Adel Abdel-MoneimAlaa AboudMohamed Abdel-Gabaar… Pages 348-355

  1. Original Article

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

Namiki IzumiTetsuo TakeharaKazuaki Chayama… Pages 356-367

September 2018

  1. Editorial

Fatty liver checkmates hepatitis B virus

Gayatri RamakrishnaNirupma Trehanpati  Pages 387-389 

  1. Original Article

Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinant

Hua LiQilu SheYu LiuYuehe DingShenghua ShiJijie Li… Pages 447-455 

  1. Original Article

Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot study

Ming-Wei LaiChao-Wei HsuChih-Lang LinRong-Nan Chien… Pages 456-464 

  1. Original Article

 Tolerable and curable treatment in HIV/HCV co-infected patients using anti-HCV direct antiviral agents: a real-world observation in China

Yuanyuan LiLinghua LiJun LiuDa-Wei ZhangFang Zhao… Pages 465-473

  1. November 2018

A changing paradigm: management and treatment of the HCV/HIV-co-infected patient

Ameer AbutalebKenneth E. ShermanPages 500-509

  1. Point of View

Hepatitis B-positive health-care workers: why they should not switch to non-exposure-prone jobs

Ankur Jindal Pages 520-522